Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$414K Buy
3,223
+75
+2% +$8.78K 0.05% 115
2026
Q1
$379K Sell
3,148
-10
-0.3% -$1.15K 0.05% 109
2025
Q4
$332K Sell
3,158
-386
-11% -$36.2K 0.05% 123
2025
Q3
$300K Buy
+3,544
New +$292K 0.04% 128

Other funds holding MRK

Berman McAleer's MRK Position: Q2 2026 in Review

Berman McAleer increased its Merck (MRK) stake by 2.4% in Q2 2026, buying an estimated $8.78K and bringing the position to 3,223 shares worth $414K. The position accounts for 0.05% of the portfolio, ranked #115.

Berman McAleer first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. 1,766 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Berman McAleer held 3,223 shares of Merck worth $414K as of Q2 2026.
  • Berman McAleer bought 75 Merck shares in Q2 2026, an estimated $8.78K.
  • Merck made up 0.05% of Berman McAleer's portfolio in Q2 2026, its #115 holding.
  • Berman McAleer first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • 1,766 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Berman McAleer's 13F filing for Q2 2026, filed 16 Jul 2026.